Markets › Stocks › COLINZ
CO

Colinz Laboratories Ltd

NSE: COLINZBSE: 531210Healthcare
₹64.22
▲ +3.78%
NSE · 15-min delayed
Mkt Cap
₹13 Cr
P / E
25.3
P / B
1.3
ROE
5.1%
52W High
₹87.91
52W Low
₹36.11
Key Metrics
Market Cap
₹13 Cr
P / E
25.34
P / B
1.34
EV / EBITDA
9.45
ROCE
7.1%
ROE
5.1%
Debt / Equity
0.04
Book Value
₹47.93
EPS
₹2.04
Div Yield
0.0%
Face Value
-
Revenue · ₹ Cr
8
FY20
6
FY21
7
FY22
7
FY23
7
FY24
7
FY25
6
FY26
Net Profit · ₹ Cr
0
FY20
0
FY21
0
FY22
0
FY23
0
FY24
0
FY25
1
FY26
EPS · ₹ per share
₹0.2
FY19
₹1.0
FY21
₹0.7
FY22
₹1.8
FY23
₹1.9
FY24
₹2.0
FY25
₹2.0
FY26
Q1 2026 snapshot
Sales
₹2 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.68
Scorecard · 7 axes
Quality
Avg
57/100
Valuation
Avg
25.3×
Growth
Weak
+3.9%
Profitability
Weak
6.1%
Performance
Weak
+1.0%
Entry Point
Good
73%
Red Flags
Strong
0 flags
Shareholding Pattern
66.0%Promoter
Promoter66.0%
Public34.0%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1.541.531.641.551.511.92
Net Profit0.0530.150.1190.1410.0840.171
NPM %3.5%9.8%7.3%9.1%5.5%8.9%
AlertPre-trade